Skip to content
    Drishti.money
    Earnings calls

    Guj. Themis Bio. concall ledger

    Every earnings call for GUJTHEM — management tone, guidance, KPIs and promise tracking, quarter by quarter.

    GUJTHEM · 5 transcripts · Healthcare · latest Q2 FY24
    Q2 FY24Published 07 Nov 2023Call held 07 Nov 2023

    GUJTHEM Q2 FY24 Earnings Call Transcript & Analysis

    Revenue₹39.65 cr−17% YoYEBITDA₹16.82 cr−31% YoYEBITDA Margin42.42%−9% YoYPAT₹12.54 cr−33% YoYEPS₹8.63

    Revenue (Q2 FY24) ₹40 cr (−17% YoY); EBITDA (Q2 FY24) ₹17 cr (−31% YoY); EBITDA Margin (Q2 FY24) 42.42% (−9% YoY). Q2 FY24 Revenue stood at Rs.39.65 crores, a 16.86% decline YoY.

    Read full transcript & analysis
    Q4 FY23Published 15 May 2023Call held 15 May 2023

    GUJTHEM Q4 FY23 Earnings Call Transcript & Analysis

    FY23 Revenue₹148.97 cr+30% YoYFY23 EBITDA₹74.22 cr+28% YoYFY23 EBITDA Margin49.82%FY23 PAT₹57.97 cr+33% YoYFY23 EPS₹39.9

    FY23 Revenue ₹149 cr (+30% YoY); FY23 EBITDA ₹74 cr (+28% YoY); FY23 EBITDA Margin 49.82%. Q4 FY23 Revenue at INR28.17 crores, a 2.05% YoY decline.

    Read full transcript & analysis
    Q3 FY23Published 06 Feb 2023Call held 06 Feb 2023

    GUJTHEM Q3 FY23 Earnings Call Transcript & Analysis

    Q3 FY23 Revenue₹28.2 cr+51% YoYQ3 FY23 EBITDA₹12.1 cr+24% YoYQ3 FY23 EBITDA Margin43%Q3 FY23 PAT₹9.8 cr+38% YoYQ3 FY23 Net Profit Margin34.8%

    Q3 FY23 Revenue ₹28 cr (+51% YoY); Q3 FY23 EBITDA ₹12 cr (+24% YoY); Q3 FY23 EBITDA Margin 43.0%. Q3 FY23 Revenue stood at INR 28.2 crores, marking a 51.4% rise year-on-year.

    Read full transcript & analysis